We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+11.02%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$198M
AUM Growth
+$37.9M
Cap. Flow
+$42.3M
Cap. Flow %
21.36%
Top 10 Hldgs %
27.74%
Holding
86
New
20
Increased
29
Reduced
15
Closed
16

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$3.48M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$2.5M
3
CFN
CAREFUSION CORPORATION
CFN
+$2.48M
4
CAH icon
Cardinal Health
CAH
+$2.38M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$2.37M

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$3.35M
2
AMGN icon
Amgen
AMGN
+$3.08M
3
CVS icon
CVS Health
CVS
+$2.6M
4
BSX icon
Boston Scientific
BSX
+$2.39M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.1M

Sector Composition

Rank Sector Weight
1 Healthcare 88.23%
2 Financials 0%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
26
Biogen
BIIB
$30.6B
$3.15M 1.59%
10,000
+3,000
+43% +$903K
TMH
27
DELISTED
Team Health Holdings Inc
TMH
$3M 1.51%
60,000
-9,470
-14% -$458K
TRNX
28
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$2.92M 1.48%
125,000
+35,000
+39% +$727K
BMY icon
29
Bristol-Myers Squibb
BMY
$132B
$2.91M 1.47%
60,000
-22,780
-28% -$1.12M
TEVA icon
30
Teva Pharmaceuticals
TEVA
$42.1B
$2.88M 1.46%
55,000
-14,350
-21% -$733K
ICLR icon
31
Icon
ICLR
$12.8B
$2.83M 1.43%
60,000
+35,000
+140% +$1.51M
UAM
32
DELISTED
Universal American Corp
UAM
$2.71M 1.37%
325,000
+25,000
+8% +$190K
CFN
33
DELISTED
CAREFUSION CORPORATION
CFN
$2.66M 1.34%
+60,000
New +$2.48M
WCG
34
DELISTED
Wellcare Health Plans, Inc.
WCG
$2.61M 1.32%
+35,000
New +$2.5M
FRX
35
DELISTED
FOREST LABORATORIES INC
FRX
$2.58M 1.3%
26,100
+1,100
+4% +$103K
CELG
36
DELISTED
Celgene Corp
CELG
$2.58M 1.3%
15,000
-24,160
-62% -$1.84M
JAZZ icon
37
Jazz Pharmaceuticals
JAZZ
$16.7B
$2.48M 1.25%
+16,900
New +$2.34M
HSP
38
DELISTED
HOSPIRA INC
HSP
$2.44M 1.23%
47,397
-2,603
-5% -$124K
ALXN
39
DELISTED
Alexion Pharmaceuticals
ALXN
$2.34M 1.18%
+15,000
New +$2.37M
ACH
40
Accendra Health
ACH
$107M
$2.27M 1.15%
66,900
-2,040
-3% -$69.9K
ENDP
41
DELISTED
Endo International plc
ENDP
$2.16M 1.09%
30,800
+10,800
+54% +$722K
STJ
42
DELISTED
St Jude Medical
STJ
$2.08M 1.05%
30,000
– –
HNT
43
DELISTED
HEALTH NET INC
HNT
$2.08M 1.05%
+50,000
New +$1.86M
SCAI
44
DELISTED
Surgical Care Affiliates, Inc.
SCAI
$1.95M 0.99%
67,207
+3,335
+5% +$97.5K
HUM icon
45
Humana
HUM
$46.3B
$1.92M 0.97%
15,000
-9,170
-38% -$1.09M
VRTX icon
46
Vertex Pharmaceuticals
VRTX
$133B
$1.89M 0.96%
+20,000
New +$1.4M
HRC
47
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$1.78M 0.9%
42,808
+7,808
+22% +$304K
GRFS
48
Grifois
GRFS
$5.48B
$1.76M 0.89%
+80,000
New +$1.67M
AMN icon
49
AMN Healthcare
AMN
$1.42B
$1.74M 0.88%
141,106
+66,000
+88% +$789K
A icon
50
Agilent Technologies
A
$42B
$1.72M 0.87%
41,940
-6,990
-14% -$281K
1
2
3 4

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return

Sivik Global Healthcare's Q2 2014 Portfolio in Review

As of Q2 2014, Sivik Global Healthcare held 86 positions worth $198M, up 24% from $160M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Sivik Global Healthcare deployed $42.3M of net new capital in Q2 2014, opening 20 new positions and adding to 29 existing holdings. Its largest new stake was Shire pic: 20,000 shares worth $4.71M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 89% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Celgene Corp, an estimated $1.84M trimmed.

  • Sivik Global Healthcare's largest Q2 2014 buy was Shire pic: 20,000 shares worth $4.71M.
  • Sivik Global Healthcare added most to Cardinal Health in Q2 2014, an estimated $2.38M increase.
  • Sivik Global Healthcare's biggest Q2 2014 reduction was Celgene Corp, cutting an estimated $1.84M.
  • Sivik Global Healthcare fully exited Aetna Inc in Q2 2014, selling an estimated $3.35M.
  • Sivik Global Healthcare's ten largest holdings make up 28% of its $198M portfolio in Q2 2014.
  • Sivik Global Healthcare opened 20 new positions and closed 16 in Q2 2014.
  • Sivik Global Healthcare's portfolio value rose 24% quarter-over-quarter to $198M.

Based on Sivik Global Healthcare's 13F filing for Q2 2014, filed 3 Jul 2014.